https://stock.noler.com/us/stock/bio-reference-laboratories-inc https://stock.noler.com/us/stock/bio-reference-laboratories-inc/accounts-payable https://stock.noler.com/us/stock/bio-reference-laboratories-inc/accounts-receivable https://stock.noler.com/us/stock/bio-reference-laboratories-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/bio-reference-laboratories-inc/accumulated-depreciation https://stock.noler.com/us/stock/bio-reference-laboratories-inc/acquired-finite-lived-intangible-asset-residual-value https://stock.noler.com/us/stock/bio-reference-laboratories-inc/acquisitions https://stock.noler.com/us/stock/bio-reference-laboratories-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/bio-reference-laboratories-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/bio-reference-laboratories-inc/additional-paid-in-capital https://stock.noler.com/us/stock/bio-reference-laboratories-inc/advertising-expense https://stock.noler.com/us/stock/bio-reference-laboratories-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/bio-reference-laboratories-inc/amended-reports-10-k https://stock.noler.com/us/stock/bio-reference-laboratories-inc/amortization https://stock.noler.com/us/stock/bio-reference-laboratories-inc/assets-noncurrent https://stock.noler.com/us/stock/bio-reference-laboratories-inc/basic-shares https://stock.noler.com/us/stock/bio-reference-laboratories-inc/business-acquisition-cost-of-acquired-entity-purchase-price https://stock.noler.com/us/stock/bio-reference-laboratories-inc/business-acquisition-purchase-price-allocation-current-assets-receivables https://stock.noler.com/us/stock/bio-reference-laboratories-inc/business-acquisition-purchase-price-allocation-current-liabilities-accounts-payable https://stock.noler.com/us/stock/bio-reference-laboratories-inc/business-acquisition-purchase-price-allocation-goodwill-amount https://stock.noler.com/us/stock/bio-reference-laboratories-inc/business-acquisition-purchase-price-allocation-notes-payable-and-long-term-debt https://stock.noler.com/us/stock/bio-reference-laboratories-inc/business-acquisition-purchase-price-allocation-other-noncurrent-assets https://stock.noler.com/us/stock/bio-reference-laboratories-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/bio-reference-laboratories-inc/buybacks-shares-repurchased https://stock.noler.com/us/stock/bio-reference-laboratories-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leased-assets-gross https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leases-balance-sheet-assets-by-major-class-net https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/bio-reference-laboratories-inc/capital-leases-lessee-balance-sheet-assets-by-major-class-accumulated-deprecation https://stock.noler.com/us/stock/bio-reference-laboratories-inc/cash-and-equivalents https://stock.noler.com/us/stock/bio-reference-laboratories-inc/cash-flow-breakdown https://stock.noler.com/us/stock/bio-reference-laboratories-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/bio-reference-laboratories-inc/common-stock-value https://stock.noler.com/us/stock/bio-reference-laboratories-inc/contractual-obligation https://stock.noler.com/us/stock/bio-reference-laboratories-inc/contractual-obligation-due-in-fifth-year https://stock.noler.com/us/stock/bio-reference-laboratories-inc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/bio-reference-laboratories-inc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/bio-reference-laboratories-inc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/bio-reference-laboratories-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/bio-reference-laboratories-inc/cost-of-services https://stock.noler.com/us/stock/bio-reference-laboratories-inc/cost-of-services-depreciation https://stock.noler.com/us/stock/bio-reference-laboratories-inc/cost-of-services-depreciation-and-amortization https://stock.noler.com/us/stock/bio-reference-laboratories-inc/cost-of-services-direct-materials https://stock.noler.com/us/stock/bio-reference-laboratories-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/bio-reference-laboratories-inc/current-assets https://stock.noler.com/us/stock/bio-reference-laboratories-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/bio-reference-laboratories-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/bio-reference-laboratories-inc/current-liabilities https://stock.noler.com/us/stock/bio-reference-laboratories-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/bio-reference-laboratories-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/bio-reference-laboratories-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/bio-reference-laboratories-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/bio-reference-laboratories-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/bio-reference-laboratories-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/bio-reference-laboratories-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/bio-reference-laboratories-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/bio-reference-laboratories-inc/debt-repaid https://stock.noler.com/us/stock/bio-reference-laboratories-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/bio-reference-laboratories-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/bio-reference-laboratories-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/bio-reference-laboratories-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/bio-reference-laboratories-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/bio-reference-laboratories-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/bio-reference-laboratories-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/bio-reference-laboratories-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/bio-reference-laboratories-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/bio-reference-laboratories-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/bio-reference-laboratories-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/bio-reference-laboratories-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/bio-reference-laboratories-inc/depreciation https://stock.noler.com/us/stock/bio-reference-laboratories-inc/depreciation-and-amortization https://stock.noler.com/us/stock/bio-reference-laboratories-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/bio-reference-laboratories-inc/diluted-shares https://stock.noler.com/us/stock/bio-reference-laboratories-inc/effective-tax-rate https://stock.noler.com/us/stock/bio-reference-laboratories-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/bio-reference-laboratories-inc/eps https://stock.noler.com/us/stock/bio-reference-laboratories-inc/eps-basic https://stock.noler.com/us/stock/bio-reference-laboratories-inc/equity-method-investments https://stock.noler.com/us/stock/bio-reference-laboratories-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/bio-reference-laboratories-inc/financing-cash-flow https://stock.noler.com/us/stock/bio-reference-laboratories-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/bio-reference-laboratories-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/bio-reference-laboratories-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/bio-reference-laboratories-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/bio-reference-laboratories-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/bio-reference-laboratories-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/bio-reference-laboratories-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/bio-reference-laboratories-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/bio-reference-laboratories-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/bio-reference-laboratories-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/bio-reference-laboratories-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/bio-reference-laboratories-inc/general-and-administrative-expense https://stock.noler.com/us/stock/bio-reference-laboratories-inc/goodwill https://stock.noler.com/us/stock/bio-reference-laboratories-inc/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/bio-reference-laboratories-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/bio-reference-laboratories-inc/gross-profit https://stock.noler.com/us/stock/bio-reference-laboratories-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/bio-reference-laboratories-inc/income-tax https://stock.noler.com/us/stock/bio-reference-laboratories-inc/income-taxes-paid https://stock.noler.com/us/stock/bio-reference-laboratories-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/bio-reference-laboratories-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/bio-reference-laboratories-inc/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/bio-reference-laboratories-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/bio-reference-laboratories-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/bio-reference-laboratories-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/bio-reference-laboratories-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/bio-reference-laboratories-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/bio-reference-laboratories-inc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/bio-reference-laboratories-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/bio-reference-laboratories-inc/interest-expense https://stock.noler.com/us/stock/bio-reference-laboratories-inc/interest-paid https://stock.noler.com/us/stock/bio-reference-laboratories-inc/inventory https://stock.noler.com/us/stock/bio-reference-laboratories-inc/investing-cash-flow https://stock.noler.com/us/stock/bio-reference-laboratories-inc/investment-income-interest https://stock.noler.com/us/stock/bio-reference-laboratories-inc/labor-and-related-expense https://stock.noler.com/us/stock/bio-reference-laboratories-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/bio-reference-laboratories-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/bio-reference-laboratories-inc/liabilities-assumed https://stock.noler.com/us/stock/bio-reference-laboratories-inc/liabilities-noncurrent https://stock.noler.com/us/stock/bio-reference-laboratories-inc/line-of-credit-facility-increase-decrease-other-net https://stock.noler.com/us/stock/bio-reference-laboratories-inc/lines-of-credit-current https://stock.noler.com/us/stock/bio-reference-laboratories-inc/long-term-debt https://stock.noler.com/us/stock/bio-reference-laboratories-inc/long-term-loans-payable https://stock.noler.com/us/stock/bio-reference-laboratories-inc/malpractice-insurance-annual-coverage-limit https://stock.noler.com/us/stock/bio-reference-laboratories-inc/malpractice-insurance-maximum-coverage-per-incident https://stock.noler.com/us/stock/bio-reference-laboratories-inc/net-cash-from https://stock.noler.com/us/stock/bio-reference-laboratories-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/bio-reference-laboratories-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/bio-reference-laboratories-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/bio-reference-laboratories-inc/net-change-in-cash https://stock.noler.com/us/stock/bio-reference-laboratories-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/bio-reference-laboratories-inc/noncash-or-part-noncash-acquisition-net-nonmonetary-assets-acquired-liabilities-assumed https://stock.noler.com/us/stock/bio-reference-laboratories-inc/number-of-businesses-acquired https://stock.noler.com/us/stock/bio-reference-laboratories-inc/number-of-reportable-segments https://stock.noler.com/us/stock/bio-reference-laboratories-inc/operating-cash-flow https://stock.noler.com/us/stock/bio-reference-laboratories-inc/operating-income https://stock.noler.com/us/stock/bio-reference-laboratories-inc/operating-leases-rent-expense-contingent-rentals https://stock.noler.com/us/stock/bio-reference-laboratories-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/bio-reference-laboratories-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/bio-reference-laboratories-inc/other-cost-of-services https://stock.noler.com/us/stock/bio-reference-laboratories-inc/other-current-assets https://stock.noler.com/us/stock/bio-reference-laboratories-inc/other-income https://stock.noler.com/us/stock/bio-reference-laboratories-inc/other-loans-payable-current https://stock.noler.com/us/stock/bio-reference-laboratories-inc/other-loans-payable-long-term https://stock.noler.com/us/stock/bio-reference-laboratories-inc/other-noncurrent-assets https://stock.noler.com/us/stock/bio-reference-laboratories-inc/other-nonoperating-expense https://stock.noler.com/us/stock/bio-reference-laboratories-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/bio-reference-laboratories-inc/patents-rejected https://stock.noler.com/us/stock/bio-reference-laboratories-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/bio-reference-laboratories-inc/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/bio-reference-laboratories-inc/preferred-shares-facts https://stock.noler.com/us/stock/bio-reference-laboratories-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/bio-reference-laboratories-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/bio-reference-laboratories-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/bio-reference-laboratories-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/bio-reference-laboratories-inc/preferred-stock-value https://stock.noler.com/us/stock/bio-reference-laboratories-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/bio-reference-laboratories-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/bio-reference-laboratories-inc/profit-loss https://stock.noler.com/us/stock/bio-reference-laboratories-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/bio-reference-laboratories-inc/property-plant-equipment https://stock.noler.com/us/stock/bio-reference-laboratories-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/bio-reference-laboratories-inc/public-float https://stock.noler.com/us/stock/bio-reference-laboratories-inc/purchase-obligation https://stock.noler.com/us/stock/bio-reference-laboratories-inc/purchase-obligation-due-in-fifth-year https://stock.noler.com/us/stock/bio-reference-laboratories-inc/purchase-obligation-due-in-fourth-year https://stock.noler.com/us/stock/bio-reference-laboratories-inc/purchase-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/bio-reference-laboratories-inc/purchase-obligation-due-in-second-year https://stock.noler.com/us/stock/bio-reference-laboratories-inc/purchase-obligation-due-in-third-year https://stock.noler.com/us/stock/bio-reference-laboratories-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/bio-reference-laboratories-inc/retained-earnings https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sales-revenue-services-gross https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sales-revenue-services-net https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-10-k https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-10-q https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-10ksb https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-10qsb https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-15-12g https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-25-nse https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-425 https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-8-k https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-ars https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-def-14a https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-defm14a https://stock.noler.com/us/stock/bio-reference-laboratories-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/bio-reference-laboratories-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/bio-reference-laboratories-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/bio-reference-laboratories-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/bio-reference-laboratories-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/bio-reference-laboratories-inc/shareholders-equity https://stock.noler.com/us/stock/bio-reference-laboratories-inc/shares-authorized https://stock.noler.com/us/stock/bio-reference-laboratories-inc/shares-issued https://stock.noler.com/us/stock/bio-reference-laboratories-inc/stock-based-compensation https://stock.noler.com/us/stock/bio-reference-laboratories-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/bio-reference-laboratories-inc/stock-granted-value-share-based-compensation https://stock.noler.com/us/stock/bio-reference-laboratories-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/bio-reference-laboratories-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/bio-reference-laboratories-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/bio-reference-laboratories-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/bio-reference-laboratories-inc/stock-repurchase-program-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/bio-reference-laboratories-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/bio-reference-laboratories-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/bio-reference-laboratories-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/bio-reference-laboratories-inc/total-assets https://stock.noler.com/us/stock/bio-reference-laboratories-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/bio-reference-laboratories-inc/total-long-term-debt https://stock.noler.com/us/stock/bio-reference-laboratories-inc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/bio-reference-laboratories-inc/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/bio-reference-laboratories-inc/valuation-allowances-and-reserves-deductions